190 related articles for article (PubMed ID: 28684074)
1. The impact of surgical intervention and antibiotics on MRONJ stage II and III - Retrospective study.
Zirk M; Kreppel M; Buller J; Pristup J; Peters F; Dreiseidler T; Zinser M; Zöller JE
J Craniomaxillofac Surg; 2017 Aug; 45(8):1183-1189. PubMed ID: 28684074
[TBL] [Abstract][Full Text] [Related]
2. Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw.
Zirk M; Wenzel C; Buller J; Zöller JE; Zinser M; Peters F
Clin Oral Investig; 2019 May; 23(5):2143-2151. PubMed ID: 30276516
[TBL] [Abstract][Full Text] [Related]
3. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
4. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
[TBL] [Abstract][Full Text] [Related]
5. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
[TBL] [Abstract][Full Text] [Related]
7. A literature review of perioperative antibiotic administration in surgery for medication-related osteonecrosis of the jaw.
Akashi M; Kusumoto J; Takeda D; Shigeta T; Hasegawa T; Komori T
Oral Maxillofac Surg; 2018 Dec; 22(4):369-378. PubMed ID: 30327979
[TBL] [Abstract][Full Text] [Related]
8. Pedicled buccal fat pad flap as a reliable surgical strategy for the treatment of medication-related osteonecrosis of the jaw.
Rotaru H; Kim MK; Kim SG; Park YW
J Oral Maxillofac Surg; 2015 Mar; 73(3):437-42. PubMed ID: 25544302
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous Healing of Mandibular Noncontinuous Defect Caused by Medication-Related Osteonecrosis of the Jaw.
Yazan M; Atil F; Kocyigit ID; Tekin U; Tuz HH; Misirlioglu M
J Craniofac Surg; 2016 Jun; 27(4):e390-2. PubMed ID: 27244207
[TBL] [Abstract][Full Text] [Related]
10. Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw.
Ruggiero SL; Kohn N
J Oral Maxillofac Surg; 2015 Dec; 73(12 Suppl):S94-S100. PubMed ID: 26608159
[TBL] [Abstract][Full Text] [Related]
11. Conservative non-surgical management in medication related osteonecrosis of the jaw: A retrospective study.
Albanese M; Zotti F; Capocasale G; Bonetti S; Lonardi F; Nocini PF
Clin Exp Dent Res; 2020 Oct; 6(5):512-518. PubMed ID: 32614524
[TBL] [Abstract][Full Text] [Related]
12. Medication-related osteonecrosis of the jaw: Surgical or non-surgical treatment?
Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
Oral Dis; 2018 Mar; 24(1-2):238-242. PubMed ID: 29480596
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis.
Hayashida S; Soutome S; Yanamoto S; Fujita S; Hasegawa T; Komori T; Kojima Y; Miyamoto H; Shibuya Y; Ueda N; Kirita T; Nakahara H; Shinohara M; Umeda M
J Bone Miner Res; 2017 Oct; 32(10):2022-2029. PubMed ID: 28585700
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Infection Recurrence After Surgical Resection of Advanced Stage Osteonecrosis of the Mandible.
Doub JB; Kang A; Lee C; Dyalram D; Shih P; Twaddell WS; Lubek JE
J Oral Maxillofac Surg; 2024 Mar; 82(3):332-340. PubMed ID: 38199239
[TBL] [Abstract][Full Text] [Related]
15. Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).
Nica DF; Riviș M; Roi CI; Todea CD; Duma VF; Sinescu C
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562600
[No Abstract] [Full Text] [Related]
16. Surgical treatment of stage 2 medication-related osteonecrosis of the jaw compared to osteomyelitis.
Kang SH; Won YJ; Kim MK
Cranio; 2018 Nov; 36(6):373-380. PubMed ID: 28854059
[TBL] [Abstract][Full Text] [Related]
17. Pain characteristics in medication-related osteonecrosis of the jaws.
Haviv Y; Geller Z; Mazor S; Sharav Y; Keshet N; Zadik Y
Support Care Cancer; 2021 Feb; 29(2):1073-1080. PubMed ID: 32601851
[TBL] [Abstract][Full Text] [Related]
18. Nasolabial Flap Improves Healing in Medication-Related Osteonecrosis of the Jaw.
Lemound J; Muecke T; Zeller AN; Lichtenstein J; Eckardt A; Gellrich NC
J Oral Maxillofac Surg; 2018 Apr; 76(4):877-885. PubMed ID: 29104029
[TBL] [Abstract][Full Text] [Related]
19. Surgical Management of Medication-Related Osteonecrosis of the Jaw Patients Related to Dental Implants.
Nisi M; Izzetti R; Gennai S; Bellini P; Graziani F; Gabriele M
J Craniofac Surg; 2020 Jun; 31(4):1037-1041. PubMed ID: 32102027
[TBL] [Abstract][Full Text] [Related]
20. Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw.
Janovska Z; Mottl R; Slezak R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):313-7. PubMed ID: 24108250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
